Anesthesia, Artery Carotid Stenosi, Artery Occlusion, Ischemia, Cerebral, Ischemic Stroke, Surgery
Conditions
Brief summary
In patients undergoing planned surgery for carotid tromendarterendectomy, a non-invasive device that registers heart rate variability is attached. Furthermore a non-invasive device that monitors cerebral oxygenation- near infrared spectroscopy as well as electroencephalography is also attached. At times when surgeons clamps the carotid artery, there will be a moment with controlled cerebral ischemia. This will be registered by the devices. The information obtained will be used to teach artificial intelligence what patterns are related to cerebral ischemia. The same procedure will be performed in patients undergoing ocklusive cerebral trombectomy, so the artificial intelligence will learn to recognize cerebral reperfusion.Blood samples will be drawn before and after cerebral ischemia may occur and will be analyzed for neurobiomarkers and cardiac biomarkers. To teach the algorithm patterns from anaesthesia and surgery in patients without pre existing neuronal injury, the same method will be applied to patients undergoing mixed abdominal surgery. This group will provide a better knowledge of neuro biomarker patterns during anesthesia and surgery.
Detailed description
The neurobiomarkers that will be analyzed for detection of cerebral ischemia is Glial Fibrillary Acidic Protein, Neurofilament light chains, S-100B, Neuron specific endolas, Total-tau. Cardiac biomarkers are troponin-t and NT-pro brain natriuretic peptide. Blood sampling will occur before anesthesia induction and 2 and 24 hours after surgery or plausible ischemia for patients undergoing surgery for carotid endarterectomy. For patients undergoing acute thrombectomy blood sampling will be performed as soon as possible after the patient has arrived to the hospital as well as 2 hours and 24 hours later. For patients undergoing mixed abdominal surgery, sampling will be done before anesthesia induction and 2 hours and 24 hours after surgery. Additionally, blood from the thrombectomy cohort and the control cohort will be analyzed by an external party OLIMK, Uppsala. This is an explorative study aiming to find new biomarkers for detection of cerebral ischemia. Blood from both cohorts will be analyzed for 384 neurology biomarkers.
Interventions
there will be NO intervention
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients planned for carotid surgery or trombectomy * Giving informed consent to participate
Exclusion criteria
* Patients that do not consent Patients with arrythmia or pacemaker
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Heart Rate variability | 2020-2030 | Changes in Heart Rate Variability from baseline. |
| Near infrared spectroscopy | 2020-2030 | Changes in Near Infrared spectroscopy from baseline. |
| Electroencephalography | 2020-2030 | Changes in electroencephalography from baseline, more precisely the Power in alpha bands, beta band, delta bands and quotas between these. |
| Biomarkers indicating cerebral ischemia in blood | 2020-2030 | Changes in levels of biomarkers in blood from baseline. Total tau, neurofilament light chains, glial fibrillary acidic protein, S-100, neuron specific endolas. |
| Biomarkers indicating cardiac ischemia in blood | 2020-2030 | Changes in levels of biomarkers in blood from baseline. Troponin T |
Countries
Sweden
Contacts
Inst Clin Sciences